Company Comparison
BioRegen Labs vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | BioRegen Labs | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Basel | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series C | Series B |
| Total Funding | $150M | $45M |
| Valuation | — | — |
What They Build
BioRegen Labs
A Basel-based regenerative medicine company with $150M in Series C funding, developing advanced regenerative therapies and technologies.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
BioRegen Labs
No investors listed.
Sector Overlap
Both BioRegen Labs and 54gene operate in Biotech.
Browse all Biotech companies →